How many insider trades does FilingIQ track for LENZ?

FilingIQ tracks 65 Form 4 insider transactions for LENZ (LENZ Therapeutics, Inc.), covering filings from Mar 21, 2024 onwards. 3 of those were filed in the last 90 days.

Are LENZ insiders net buyers or net sellers?

Across the full Form 4 history for LENZ, 10 transactions (15%) were open-market purchases and 36 (55%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does LENZ insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is LENZ in?

LENZ Therapeutics, Inc. (LENZ) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $283.80M.

LENZ insider trading

NasdaqGS Healthcare

LENZ Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

15% / 55%

Market cap

$283.80M

About LENZ Therapeutics, Inc.

LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults. LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.

Company website: www.lenz-tx.com

LENZ insider activity at a glance

FilingIQ has scored 65 insider transactions for LENZ since Mar 21, 2024. The most recent filing in our index is dated Mar 27, 2026.

Across the full history, 10 open-market purchases and 36 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on LENZ insider trades is 52.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live LENZ trades on FilingIQ Raw filings on SEC EDGAR

Latest LENZ Form 4 filings

Schimmelpennink Evert B. President, CEO and Secretary

P Mar 27, 2026

Chevallard Daniel R. Chief Financial Officer

P Mar 27, 2026

Chevallard Daniel R. Chief Financial Officer

P May 14, 2024

RA Capital Nexus Fund II, L.P.

P Mar 21, 2024

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading LENZ

Schimmelpennink Evert B.

3 trades · score 74.0

Frequently asked

How many insider trades does FilingIQ track for LENZ?: FilingIQ tracks 65 Form 4 insider transactions for LENZ (LENZ Therapeutics, Inc.), covering filings from Mar 21, 2024 onwards. 3 of those were filed in the last 90 days.
Are LENZ insiders net buyers or net sellers?: Across the full Form 4 history for LENZ, 10 transactions (15%) were open-market purchases and 36 (55%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does LENZ insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is LENZ in?: LENZ Therapeutics, Inc. (LENZ) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $283.80M.

Methodology & sources

Every LENZ insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.